Lacour JP, Khemis A, Giordano-Labadie F, Martin Lu, Staumont-Salle D, Hacard F, Tian H, McBride D, Hollis K, Hunter S, Martin L, Lamirand A, Le Guen S, Balp MM, Berard F. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study). Eur J Dermatol. 2018 Dec 1. doi: 10.1684/ejd.2018.3446
Mauskopf J, Paramore C, Lee WC, McBurney CR, Snyder EH. Drug persistence is similar with rivastigmine and donepezil in Alzheimer's disease patients. Neurobiol Aging. 2004 Jan 1;25:S204.
Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.
Ofman J, Hauber B, Deal L, Mauskopf J, Snyder E. Costs and benefits of rivastigmine treatment for Alzheimer's disease in the US. Neurobiol Aging. 2002 Jan 1;23(1):476.